Mucosal melanoma – Market outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2020 To 2030
Mucosal melanoma arises from melanocytes that reside in a range of internal epithelial tissues of ectodermal origin. The oral cavity, nose and paranasal sinuses, genital tract, and anorectal region are the commonest primary sites for mucosal melanoma. Epidemiology- Mucosal melanoma is a rare disease, accounting for only 0.03% of new cancer diagnoses, According to Thelansis disease modeling data, results of literature reviews, surveys, and registry analyses, estimated 93,760 cases of melanoma were diagnosed in the United States in 2020, ~1.6% of them are on the mucosal surfaces of the body. The competitive landscape of Mucosal melanoma includes country-specific approved and pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are tracked and supplemented with analyst commentary. KOLs insights of Mucosal melanoma across 8 MM market from the center of Excellence/ Public/ Private hospitals participated in th...